ArticleScientific reports2025
Secondary metabolite biosynthetic gene clusters and microbial diversity as predicted by shotgun metagenomic sequencing approach in hospitals and pharmaceutical industry wastes.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrated Multi-Omics Analysis of a Periplaneta americana Symbiont Streptomyces sampsonii Strain WA1-19 Against Candida albicans.Microbial biotechnology · 2026Article
- Anticancer compounds from Streptomyces: insights from metagenomics and mechanistic perspective.Folia microbiologica · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hospital and pharmaceutical industry wastes harbor a diverse microbial community influenced by their complex chemical composition, including antibiotic-rich compounds originating from soil microorganisms. This study employs a shotgun metagenomic approach to comprehensively characterize the microbial composition of hospital and Pharmaceutical industry wastes for the first time in Ethiopia. Metagenomic DNA was extracted and used to construct a whole-genome shotgun library, which was subsequently sequenced using the Illumina HiSeq1500 platform. Taxonomic analysis revealed that bacteria were the predominant domain across all samples, followed by eukaryotes and archaea. Among the bacterial phyla, Pseudomonadota was the most prevalent in both hospital and pharmaceutical waste samples. At the genus level, Pseudomonas and Pedobacter were the most abundant taxa, followed by Flavobacterium and Streptomyces. Notably, Streptomyces exhibited higher-than-expected abundance in the waste metagenome, suggesting a potential adaptive response to environmental stressors. Across all samples, Pedobacter and Pseudomonas were consistently the most dominant bacterial genera. Functional analysis using gene ontology (GO) annotations highlighted the predominance of metabolic and biosynthetic processes. Further investigation revealed an enrichment of ATP-binding cassette (ABC) transporter protein families and winged-helix protein domains, both of which are linked to antibiotic resistance, metabolite translocation, and antibiotic biosynthesis regulation. KEGG pathway analysis identified key biosynthetic pathways, including terpenoid and polyketide biosynthesis, as well as beta-lactam antibiotic production. Additionally, antiSMASH analysis detected multiple biosynthetic gene clusters (BGCs), including those encoding terpenes, bacteriocins, and non-ribosomal peptide synthetases. Overall, this study underscores the adaptive potential of microorganisms inhabiting industrial waste environments, highlighting their genomic capacity to produce bioactive secondary metabolites in response to toxic compounds. These findings provide valuable insights into microbial resilience and the potential for biotechnological applications in bioremediation and drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.